CU6.AX · CLARITY PHARMACEUTICALS LTD
Australia · RS rating 12 · As of 2026-10-14
| Price | 1.83 AUD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 18 / 20 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 7 / 12 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +62.8% |
| Market cap (USD) | $479.0M |